Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07369856
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Diagnosis of heart failure according to the Universal Definition
* Use of loop diuretics
* Residing in VCH or PHC regions
Group-specific inclusion:
Group 1: Congestion score ≥5 OR objective congestion; stable furosemide ≥1 week Group 2: NYHA I-II; congestion score \<5; no recent HF hospitalization; stable furosemide ≥1 month Group 3: First 100 eligible patients not meeting criteria for Groups 1 or 2
Exclusion Criteria:
* eGFR \<20 mL/min/1.73m²
* Renal replacement therapy
* High-risk clinical status requiring hospitalization
* Inability to consent or perform required urine sampling
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07369856
Study Brief:
Protocol Section:
NCT07369856